Chapter 1. Project Description

Coordinator:Peter I. Saparin, PhDMax Plack Institute of Colloids and Interfaces, Golm, Germany
 Wolfgang Gowin, MD, PhDFormer Coordinator til July 31, 2004
Team Members:Peter Fratzl, PhDMax Plack Institute of Colloids and Interfaces, Golm, Germany
 Richard Weinkamer, PhDMax Plack Institute of Colloids and Interfaces, Golm, Germany
 Dieter Felsenberg, MD, PhDFree University Berlin, Germany
 Gisela Beller, MDFree University Berlin, Germany
 Jürgen Kurths, PhDUniversity Potsdam, Germany
 Norbert Marwan, PhDUniversity Potsdam, Germany
 Jesper Skovhus Thomsen, PhDUniversity of Aarhus, Denmark
 Hans-Christian HegeZuse Institute Berlin (ZIB), Germany
 Steffen ProhaskaZuse Institute Berlin (ZIB), Germany
 Bruno Koller, PhDScanco Medical AG, Switzerland
 Thomas von der Haar, PhDSiemens AG, Forchheim, Germany
 Christian AsbeckSiemens AG, Forchheim, Germany
 Malte WesterhoffIndeed - Visual Concepts, Berlin, Germany
Project User Group:Roche Pharmaceuticals, Switzerland 
 Hewlett Packard (HP), Germany 

After the contract was signed on December 14, 2000; the project started at the beginning of January 2001. The first phase was successfully completed by the end of December 2002. These first two years are documented in the Final Report. The project team applied successfully for a three-year-extension, and received peer-reviewed approval for that in December 2002. The second phase started in January 2003 and will last until the end of September 2005.

The project develops the tools to evaluate structural loss in bone architecture and gains new quantitative information about the bone metabolism in microgravity condition. This evaluation is mostly based on symbolic dynamics and measures of complexity derived from the field of nonlinear dynamics. The most precise procedure for diagnosing structural alterations will be developed and scientifically proven through the research project. The outcome of such a comprehensive diagnostic program will provide the fundamental basis for monitoring, prevention, and treatment of structural changes of the bone in microgravity condition. This will have an impact on space-flying personnel and on patients with bone diseases on Earth.

The following tasks have been solved during the first phase of the project:

At this point in time the team is mostly involved in the validation of the findings by comparison of the micro-CT-outcome with static histomorphometrical examinations.

The following tasks will be solved during the second phase of the project:

The results of this project will have an impact in the following areas:

After the successful completion of the research program the prospects will be: